Prescription drug · ANDA
1% Lidocaine Hci NDC 51662-1465
Lidocaine hydrochloride 10 mg/mL · Injection, Solution · Infiltration, Perineural · HF Acquisition Co LLC, DBA HealthFirst
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51662-1465-1Searched | 51662146501 | 20 mL in 1 VIAL, MULTI-DOSE (51662-1465-1)Marketed from Dec 13, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- 1% Lidocaine Hci
- Generic name (nonproprietary)
- 1% lidocaine hci
- Active ingredients
- Lidocaine hydrochloride — 10 mg/mL
- Dosage form
- Injection, Solution
- Route
- Infiltration, Perineural
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 088299
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 51662-1465_2b39c181-370c-c567-e063-6394a90a2a8dSPL ID 2b39c181-370c-c567-e063-6394a90a2a8dSPL set ID 999b1c7b-3495-926a-e053-2a95a90ab206RxCUI 1010033, 1010671UNII V13007Z41A
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N451662146501followed by a unit qualifier and the quantityPackage 51662-1465-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS & USAGE Lidocaine Hydrochloride Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
Excerpt only. Read the full label for complete information.